Arkolith/Insider Trading/OPNT/Form 4

Crystal Roger

Chief Executive Officer, Director, 10% OwnerOPIANT PHARMACEUTICALS, INC. (OPNT) · full profile →Form 4 · filed Mar 3, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
5 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2023Disposed to issuer(D)5K$20.00$102K0
Mar 2, 2023Disposed to issuer(D)7K$20.00$133K0
Mar 2, 2023Grant(A)7K—$07K
Mar 2, 2023Disposed to issuer(D)38K$20.00$758K0
Mar 2, 2023Disposed to issuer(D)37K$20.00$749K38K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2023Disposed to issuer(D)25K—$00
Mar 2, 2023Disposed to issuer(D)375K—$00
Mar 2, 2023Disposed to issuer(D)27K—$00
Mar 2, 2023Disposed to issuer(D)13K—$00
Mar 2, 2023Disposed to issuer(D)150K—$00
Mar 2, 2023Disposed to issuer(D)25K—$00
Mar 2, 2023Disposed to issuer(D)31K—$00

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001385508-23-000069) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML